Category Legacy Archive

A curated collection of historical presentations and early research materials preserved from the original Pharcon website.

Highly Efficient Anti-Inflammatory Cream

TOPICAL NANOEMULSIONS AS EFFECTIVE DRUG CARIERS  Rai V., et al.“Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery”Journal of Controlled Release Volume 270, 28 January 2018, Pages 203-225 TARGETED FOLLICULAR DELIVERY MINOXIDIL-FINASTERIDE TOPICAL NANOEMULSION •Water based formulation (oil-in-water nanoemulsion) …

BIODEGRADABLE MICROPARTICLES FOR LONG ACTING INJECTIONS

PLGA MICROPARTICLES WITH GLATIRAMER (COPAXONE® LAI)   Despite several methods for preparation of injectable microparticles with incorporated water-soluble component are described, the most appropriate process based on “double emulsification” approach was selected.  Briefly, the concentrated water solution of the highly water-soluble…

Emulvit-D bottle with sunlight and vitamin D3 synthesis diagram on skin

Emulvit-D

This page is part of the legacy archive of our previous website and preserves the original slide presentation describing the Emulvit D nanoemulsion formulation. Although the layout reflects an older version of the site, the scientific content remains relevant and…

Person in medical gloves holding a red capsule with digital molecular structures and pharmaceutical data overlays in the background.

Pharcon Inc. at a Glance

This 5-minute video presents a unified overview of Pharcon Inc.’s research and development portfolio, including patented technologies, formulation platforms, and delivery systems. It consolidates multiple presentations into a single visual summary. For more information, visit pharcon.ca. See the R&D section…

Infographic comparing sublingual tablet and injection.

Oral Peptide Delivery

Oral peptide delivery is especially challenging for insulin tablets due to enzymatic degradation and low permeability in the gastrointestinal tract. This brief video presentation highlights the key barriers and emerging strategies that aim to make oral insulin a practical therapeutic…

Illustration of self‑nanoemulsifying drug delivery system (SNEDDS) improving dissolution and absorption.

Self-nanoemulsifying drug delivery systems (SNEDDS)

PHARCON Inc. develops self‑nanoemulsifying drug delivery systems (SNEDDS) to enhance the delivery of poorly water‑soluble biologically active compounds. SNEDDS significantly improve solubility, absorption, bioavailability, and overall therapeutic performance. COMPARATIVE DISSOLUTION OF SNEDDS AND OIL-FILLED CAPSULES Copyright © 2026 PHARCON Inc.…